Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I dose-escalation clinical trial to evaluate the safety and immunogenicity of the EP HIV-1090 DNA vaccine in healthy, HIV-1-uninfected adult participants
Description
HVTN 048 is a Phase I clinical trial to evaluate the safety and immunogenicity of EP HIV-1090 DNA.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.